In a media briefing on Tuesday, WHO Director-General Tedros Adhanom Ghebreyesus highlighted the consequences of funding suspensions, including disruptions to HIV treatment, setbacks in polio eradication and limited resources for responding to mpox epidemics in Africa.

“The suspension of funding to PEPFAR, the President’s Emergency Plan for AIDS Relief, caused an immediate stop to HIV treatment, testing and prevention services in the 50 countries,” Tedros said.

He noted that despite a waiver for life-saving services, prevention programmes for at-risk groups remain excluded, clinics have closed, and health workers have been put on leave.

Tedros urged the US Government to reconsider its funding approach, at least until alternative solutions can be found to maintain essential health services.

Ebola outbreak in Uganda

Turning to Uganda, Tedros provided updates on the recently reported Ebola outbreak, with nine confirmed cases, including one death.

WHO has deployed emergency teams to support surveillance, treatment and infection control measures.

A vaccine trial, launched just four days after the outbreak was declared, is now underway, while approval for a therapeutics trial is pending.

To sustain the response, WHO has allocated an additional $2 million from its Contingency Fund for Emergencies,supplementing the $1 million already provided.

Conflict in DR Congo

The humanitarian crisis in the Democratic Republic of the Congo is also straining health services, with more than 900 deaths and over 4,000 injuries reported amid escalating violence in the east.

“At most, only one-third of people who need health services in North and South Kivu are able to receive them,” Tedros stated, emphasising the risks posed by infectious disease outbreaks such as mpox and cholera.

Supplies, including medicines and fuel, are running critically low, further complicating WHO’s ability to respond.

Advancing childhood cancer treatment

On a more positive note and as UN News reported on Tuesday, WHO announced progress in expanding access to childhood cancer medicines in low and middle-income countries.

“Yesterday, we began distributing childhood cancer medicines at no cost in the first two countries: Mongolia and Uzbekistan,” said Tedros, adding that shipments are planned for four more countries.

The programme is facilitated through the Global Initiative on Childhood Cancer, launched in partnership with St. Jude Children’s Research Hospital.

The initiative aims to reach 120,000 children across 50 countries over the next five to seven years, addressing stark disparities in survival rates between high-income and low-income nations.